Complexity and Network Modeling – Application in Pharma Commercial Operations
This is a members only resource. If you would like to learn more about PMSA membership, click here.
Description
Pharma organizations are undergoing changes where the focus is more on transformative medicines catering to unmet need and on smaller agile R&D cycles. Tackling a complex ecosystem of patients, providers, payers, and regulators among other entities requires organizations to strengthen their predictive modeling capabilities. Traditional predictive modeling can be complemented further through application of System Dynamics, Networking Modeling, and Simulation. These models enable future insights while utilizing historical behavior, provide the ability to incorporate real-world feedback instead of reliance only on linear cause-effect relationships, and account for a more exhaustive set of parameters that capture customer interactions.
Various industries are utilizing these System Dynamics and Network Modeling techniques to enhance models for product launch, market mix, and ROI optimization, among others. Pharma companies can benefit from these methods to improve their commercialization effectiveness across similar problem areas. One such instance is where we helped a pharmaceutical company leverage system dynamics to model the effect of a biosimilar launch on the market share. Being able to simulate the impact of a biosimilar launch made the organization more proactive and nimble in modifying strategies. In this webinar, we will look to answer two key questions:
- How have network modeling and system dynamics been applied by pharma and organizations across other industries to drive business value?
- How can these techniques help pharma commercialization teams tackle the uncertain and complex ecosystem?
Presenters:
- Sridhar Turaga, Head of Technology, Mu Sigma Inc.